Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-04-02

Clinical Trial Update: Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus [Phase 2]

View source ↗

Summary

A phase 2 clinical trial update describing the safety and tolerability study of levetiracetam for treating status epilepticus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Medical Center Haaglanden | Conditions: Status Epilepticus | Phase 2 | Status: UNKNOWN